Diagnostic quality and complications of hysterosalpingography: Oil- versus water-soluble contrast media - A randomized prospective study

Radiology

Volumn 179, Issue 1, 1991, Pages 69-74

  Lindequist, Steen ^a   Justesen, Per ^a   Larsen, Claus ^a   Rasmussen, Finn ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Contrast media, comparative studies, 85.1282; Contrast media, effects, 85.2171, 85.2172, 85.2175; Fallopian tubes, 853.2172, 853.2175; Pelvis, hemorrhage, 85.217; Sterility, 85.2175; Uterus, hemorrhage, 854.217; Uterus, radiography, 854.1282

Indexed keywords

IODINATED POPPYSEED OIL; IOHEXOL; IOXAGLIC ACID; MEGLUMINE DIATRIZOATE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYSTEROSALPINGOGRAPHY; IMAGE QUALITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

COMPARATIVE STUDY; CONTRAST MEDIA; DIATRIZOATE MEGLUMINE; ETHIODIZED OIL; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMAN; HYSTEROSALPINGOGRAPHY; IOHEXOL; IOXAGLIC ACID; PAIN; PROSPECTIVE STUDIES; SOLUBILITY; UTERINE HEMORRHAGE;

EID: 0026013136     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.179.1.1848715     Document Type: Article

References (31)

1. Siegler AM. Hysterosalpingography. Fertil Steril 1893; 40:139-158.
2. Nielsen DT, Justesen P, Rasmussen F. A comparative study of hysterosalpingography and endoscopy/laparotomy in infertile women. Eur J Radiol 1987; 7:260-262.
3. Rindfleisch W. Darstellung des cavum uteri. Klin Wochenschr 1910; 47:780.
4. Heuser C. Lipiodol in the diagnosis of pregnancy. Lancet 1925; 2:1111-1112.
5. Nielsen PH. Injuries caused by hysterosalpingography. Acta Obstet Gynecol Scand 1946; 26:565-597.
6. Faris AM, McMurray A. Uterosalpingography: reports of a fatality. Texas Med 1947; 42:592-597.
7. Zachariae F. Venous and lymphatic intravasation in hysterosalpingography. Acta Obstet Gynecol Scand 1954; 34:131-149.
8. Gajzágó E. Ein im anschluss an hysterosalpingographie durch ölembolie verursachter todesfall. Zentralbl Gynakol 1931; 55:543-545.
9. Woltz JHE, Bradford WZ, Bradford WB, McCoy JB. Complications of hysterosalpingography. Am J Obstet Gynecol 1958; 76:736-741.
10. Measday B. An analysis of the complications of hysterosalpingography. J Obstet Gynaec Brit Emp 1960; 67:663-667.
11. Siegler AM. Dangers of hysterosalpingography. Obstet Gynecol Surv 1967; 22:284-308.
12. Malter IJ, Fox RM. Prolonged oviduct retention of iodized contrast medium. Obstet Gynecol 1972; 40:221-224.
13. Bateman BG, Nunley WC, Kitchin JD. Intravasation during hysterosalpingography using oil-based contrast medium. Fertil Steril 1980; 34:439-443.
14. Soules MR, Spadoni LR. Oil versus aqueous media for hysterosalpingography: a continuing debate based on many opinions and few facts. Fertil Steril 1982; 38:1-11.
15. Nunley WC, Bateman BG, Kitchin JD, Pope TL. Intravasation during hysterosalpingography using oil-base contrast medium: a second look. Obstet Gynecol 1987; 70:309-312.
16. Mackey RA, Glass RH, Olson LE, Vaidya R. Pregnancy following hysterosalpingography with oil and water soluble dye. Fertil Steril 1971; 22:504-507.
17. Fullenlove TM. Experience with over 2,000 uterosalpingographies. AJR 1969; 106:463-471.
18. Moore DE. Pain associated with hysterosalpingography: Ethiodol versus Salpix media. Fertil Steril 1982; 38:629-631.
19. Davies AC, Keightley A, Borthwick-Clarke A, Walters HL. The use of low-osmolality contrast medium in hysterosalpingography: comparison with a conventional contrast medium. Clin Radiol 1985; 36:533-536.
20. Marshak RH, Poole CS, Goldberger MA. Hysterography and hysterosalpingography: an analysis of 2,500 cases with special emphasis on the technique and safety of the procedure. Surg Gynecol Obstet 1950; 91:182-192.
21. Winfield AC, Maxon WS, Harding DR, Diggs J, Wentz AC. Hexabrix as a contrast agent for hysterosalpingography. Radiology 1984; 152:232-233.
22. Stumpf PG, March CM. Febrile morbidity following hysterosalpingography: identification of risk factors and recommendations for prophylaxis. Fertil Steril 1980; 33:487-492.
23. Pittaway DE, Winfield AC, Maxson W, Daniell J, Herbert C, Wentz AC. Prevention of acute pelvic inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis. Am J Obstet Gynecol 1983; 147:623-626.
24. Møller BR, Allan J, Toft B, et al. Pelvic inflammatory disease after hysterosalpingography associated with Chlamydia trachomatis and Mycoplasma hominis. Br J Obstet Gynaecol 1984; 91:1181-1184.
25. Dan U, Oelsner G, Gruberg L, Ezra D, Menezer J. Cerebral embolization and coma after hysterosalpingography with oil-soluble contrast medium. Fertil Steril 1990; 53:939-940.
26. Kantor HJ, Kamholz JH, Smith AL. Foreign-body granulomas following the use of salpix. Obstet Gynecol 1956; 7:171-174.
27. Eisenberg AD, Winfield AC, Page DL, Holburn GE, Schifter T, Segars JH. Peritoneal reaction resulting from iodinated contrast material: comparative study. Radiology 1989; 172:149-151.
28. Brown WE, Jennings AF, Bradbury JT. The absorption of radiopaque substances used in hysterosalpingography. AJR 1949; 58:1041-1053.
29. de Boer AD, Vemer HM, Willemsen WNP, Sanders FBM. Oil or aqueous contrast media for hysterosalpingography: a prospective randomized, clinical study. Eur J Obstet Gynecol Biol 1988; 28:65-68.
30. Bateman BG, Nunley WC, Kitchin JD, Kaiser DL. Utility of the 24-hour delay hysterosalpingogram film. Fertil Steril 1987; 47:613-617.
31. Rasmussen F, Lindequist S, Larsen C, Justesen P. Therapeutic effect of hysterosalpingography: oil- versus water-soluble contrast media - a randomized prospective study. Radiology 1991; 179:75-78.